BU-NOT-SET

CONTACT US
Overcoming the challenges surrounding manufacturing oncolytic viruses
  • Biologics
Virus
Insight
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
  • Drug product
  • Industry trends
DCAT insights
Insight
Developing a robust dissolution method for low-dose formulations
  • Analytical chemistry
  • Drug product
low-dose formulation
White paper
Sustainability report 2022
  • Sustainability
Sustainability report 2022
Report
Navigating the changing oral solid dose landscape
  • Drug product
  • Industry trends
Oral solid dose
Insight
The opportunities and obstacles of filling and packaging pre-filled syringes
  • Drug product
  • Manufacturing
pre-filled syringes
Insight
Tips for facilitating a successful tech transfer between sponsor and CDMO
  • Drug product
  • Industry trends
Tech transfer
Insight
Alternative drug delivery formulation & device expertise
  • Drug product
  • Industry trends
Industry trends
Insight
The 3 key trends shaping the CDMO industry in 2023 and beyond
  • Industry trends
CDMO trends
Insight
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products
Insight
  • Manufacturing
FDA inspection success at Recipharm’s site in Bengaluru, India
Fact sheet
  • Drug product
  • Manufacturing
Lyophilisation Services